Mirodenafil: a new PDE5 inhibitor for the treatment of erectile dysfunction

被引：0
|
作者：
机构：
来源：
Nature Clinical Practice Urology | 2009年 / 6卷 / 2期
关键词：
D O I：
10.1038/ncpuro1281
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：60 / 60
相关论文
共 50 条
  • [11] Combination of Vacuum Erection Device and PDE5 Inhibitors as Salvage Therapy in PDE5 Inhibitor Nonresponders with Erectile Dysfunction
    Canguven, Onder
    Bailen, James
    Fredriksson, William
    Bock, David
    Burnett, Arthur L.
    JOURNAL OF SEXUAL MEDICINE, 2009, 6 (09): : 2561 - 2567
  • [12] PDE5 inhibitors beyond erectile dysfunction
    P Sandner
    J Hütter
    H Tinel
    K Ziegelbauer
    E Bischoff
    International Journal of Impotence Research, 2007, 19 : 533 - 543
  • [13] Oral PDE5 Inhibitors for Erectile Dysfunction
    Murphy, Matthew
    Demers, Jill M.
    Ostroff, Marissa L.
    Ostroff, Jared L.
    US PHARMACIST, 2018, 43 (06) : 29 - 33
  • [14] PDE5 inhibitors beyond erectile dysfunction
    Sandner, P.
    Huetter, J.
    Tinel, H.
    Ziegelbauer, K.
    Bischoff, E.
    INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH, 2007, 19 (06) : 533 - 543
  • [15] Continuous use of PDE5 inhibitors in the treatment of erectile dysfunction: New insights and opportunities
    Maria Puigvert, Ana
    Prieto, Rafael
    Garcia, Ferran
    REVISTA INTERNACIONAL DE ANDROLOGIA, 2018, 16 (01): : 28 - 33
  • [16] Efficacy and Safety of Mirodenafil, A New Oral Phosphodiesterase Type 5 Inhibitor, for Treatment of Erectile Dysfunction
    Paick, Jae-Seung
    Ahn, Tai Y.
    Choi, Hyung K.
    Chung, Woo-Sik
    Kim, Je J.
    Kim, Sae C.
    Kim, Sae W.
    Lee, Sung W.
    Min, Kweon S.
    Moon, Ki H.
    Park, Jong K.
    Park, Kwangsung
    Park, Nam C.
    Suh, Jun-Kyu
    Yang, Dae Y.
    Jung, Hyung-Gi
    JOURNAL OF SEXUAL MEDICINE, 2008, 5 (11): : 2672 - 2680
  • [17] Pyrazolopyrimidinone Based Selective Inhibitors of PDE5 for the Treatment of Erectile Dysfunction
    Hudwekar, Abhinandan D.
    Kotwal, Pankul
    Dar, Mohd. Ishaq
    Balgotra, Shilpi
    Dogra, Ashish
    Kour, Jaspreet
    Chobe, Santosh S.
    Nandi, Utpal
    Hussain Syed, Sajad
    Sawant, Sanghapal D.
    CHEMISTRY & BIODIVERSITY, 2023, 20 (04)
  • [18] TREATMENT OF ERECTILE DYSFUNCTION WITH PHOSPHODIESTERASE TYPE 5 INHIBITOR (PDE5 INH) IN MALE PARTNER OF WOMEN WITH VAGINISMUS
    Ozkara, H.
    Akkus, E.
    Dinc, S.
    Alici, B.
    Tek, B.
    JOURNAL OF SEXUAL MEDICINE, 2011, 8 : 437 - 438
  • [19] Rigiscan evaluation of TA-1790, a novel PDE5 inhibitor for the treatment of men with erectile dysfunction
    Lewis, RW
    Hellstrom, WJG
    Gittelman, M
    McMurray, JG
    Padma-Nathan, H
    Young, J
    Steidle, C
    Peterson, CA
    JOURNAL OF UROLOGY, 2004, 171 (04): : 316 - 316
  • [20] Selectivity of Avanafil, a PDE5 Inhibitor for the Treatment of Erectile Dysfunction: Implications for Clinical Safety and Improved Tolerability
    Wang, Run
    Burnett, Arthur L.
    Heller, Warren H.
    Omori, Kenji
    Kotera, Jun
    Kikkawa, Kohei
    Yee, Shiyin
    Day, Wesley W.
    DiDonato, Karen
    Peterson, Craig A.
    JOURNAL OF SEXUAL MEDICINE, 2012, 9 (08): : 2122 - 2129
12345